LINDON, Utah, February 9, 2017 /PRNewswire/ --
(FVRG), a leader in the direct marketing
"The European Prodigy-5 Tour was a great success," commented ForeverGreen CEO, Ron Williams. "The event attendance and positive response from new and current members during the tour stops are great indicators for a stronger 2017. After sitting down with our top leaders in the European Union, it is evident that the FGX Model will play a big part in our future success."
The company has previously announced it will consolidate other products into this global model in order to drive sales, beginning with Frequensea Pro from a bottled format to a powdered format.
For more information on ForeverGreen's products, visit http://www.forevergreen.org.
ForeverGreen Worldwide Corporation develops, manufactures and distributes an expansive line of all natural whole foods and products to North America, Australia, Europe, Asia, Africa and South America, including their new global Xpress offering Prodigy-5. Additional products include PowerStrips, SolarStrips and BeautyStrips. They also offer their North America weight-management line Ketopia, along with FrequenSea, a whole-food beverage with industry exclusive marine phytoplankton, immune support and weight management products, and Pulse-8 powdered L-arginine formula.
This press release contains certain forward-looking statements. Investors are cautioned that certain statements in this release are "forward-looking statements" and involve both known and unknown risks, uncertainties and other factors. Such uncertainties include, among others, certain risks associated with the operation of the company described above. The company's actual results could differ materially from expected results.
Contact: ForeverGreen Worldwide Corporation Craig Smith, +1-801-655-5500 email@example.com
Brokers and Analysts: Chesapeake Group +1-410-825-3930 firstname.lastname@example.org
SOURCE ForeverGreen Worldwide Corporation
Subscribe to our Free Newsletters!
Drug hypersensitivity is an adverse reaction that occurs due to an interaction between a drug and ...
Stiff joints are a major problem for the elderly, as the joints tend to wear-and-tear with ...
Uterine/Endometrial cancer is the sixth most common cancer in women worldwide. Uterine cancer ...View All